Overall Status

Completed (43)

Active, not recruiting (3)

Not yet recruiting (2)

Recruiting (2)

Approved for marketing (1)

Terminated (1)

Withdrawn (1)

Phase

phase 2 (11)

phase 3 (10)

n/a (5)

phase 1 (5)

phase 1/phase 2 (2)

phase 2/phase 3 (2)

phase 4 (2)

early phase 1 (1)

Study Documents

Intervention Type

biological (20)

drug (20)

other (6)

behavioral (2)

combination product (2)

diagnostic test (1)

dietary supplement (1)

genetic (1)

Funder Type

Industry (39)

Other (13)

NIH (1)

Study Type

Interventional (38)

Observational (13)

Expanded Access (1)

Observational [Patient Registry] (1)

Palivizumab

Showing 51 - 53 of 53

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cancer Trial in Seattle (palivizumab, ribavirin)

Completed

Cancer

palivizumab
ribavirin

Seattle, Washington

Fred Hutchinson Cancer Research Center

Mar 31, 2010

-Unhealthy Children With a History of Prematurity Trial in Palo Alto (MEDI-493)

Completed

-Unhealthy Children With a History of Prematurity

MEDI-493

Palo Alto, California

Packard Children's Hospital at Stanford

Nov 12, 2010

Hospitalizations and Respiratory Tract Infections in Premature

Completed

Respiratory Syncytial Virus Infections

Birmingham, Alabama
+58 more

Feb 3, 2009